Clinical Trial Update: Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating topical calcitriol (0.0003%), tacrolimus (0.1%), and petrolatum for pityriasis alba has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pityriasis Alba

Drugs mentioned

• Protopic (tacrolimus)
• Rocaltrol (calcitriol)

Snippet

Sponsor: Universidad Autonoma de San Luis Potosí | Conditions: Pityriasis Alba | Phase 4 | Status: COMPLETED